Literature DB >> 19460091

Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia.

Ali A El Solh1, Morohunfolu E Akinnusi, Ziad Alfarah, Anil Patel.   

Abstract

OBJECTIVES: To compare the 2003 community-acquired pneumonia (CAP) guideline and the 2005 healthcare-associated pneumonia (HCAP) guideline on time to clinical stability, length of hospital stay, and mortality in nursing home patients hospitalized for pneumonia.
DESIGN: Retrospective study.
SETTING: Three tertiary-care hospitals. PARTICIPANTS: Three hundred thirty-four nursing home patients. MEASUREMENTS: Patients were classified according to the antibiotic regimens they received based on the 2003 CAP guideline or the 2005 HCAP guideline. Time to clinical stability, time to switch therapy, and mortality were evaluated in an intention-to-treat analysis. A multivariate survival model using propensity analysis was used to adjust for heterogeneity between the two groups.
RESULTS: Of the 334 patients, 258 (77%) were treated according to the 2003 HCAP guideline. Time to clinical stability did not differ between those treated according to the 2003 CAP or the 2005 HCAP guidelines. Only the Pneumonia Severity Index (P=.006) and multilobar involvement (P=.005) were significantly associated with delay in achieving clinical stability. Adjusted in-hospital and 30-day mortality were comparable in both cohorts (odds ratio (OR)=0.87, 95% confidence interval (CI)=0.49-1.34, and OR=0.79, 95% CI=0.42-1.31, respectively), although time to switch therapy and length of stay were longer for those treated according to the 2005 HCAP guideline.
CONCLUSION: In hospitalized nursing home patients with pneumonia, treatment with an antibiotic regimen according to the 2003 CAP guideline achieved comparable time to clinical stability and in-hospital and 30-day mortality with a regimen based on the 2005 HCAP guideline.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460091     DOI: 10.1111/j.1532-5415.2009.02279.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

1.  Guideline-based antibiotics and mortality in healthcare-associated pneumonia.

Authors:  Karl J Madaras-Kelly; Richard E Remington; Kevin L Sloan; Vincent S Fan
Journal:  J Gen Intern Med       Date:  2012-03-07       Impact factor: 5.128

2.  Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.

Authors:  Brandon J Webb; Kristin Dascomb; Edward Stenehjem; Holenarasipur R Vikram; Neera Agrwal; Kenneth Sakata; Kathryn Williams; Bruno Bockorny; Kavitha Bagavathy; Shireen Mirza; Mark Metersky; Nathan C Dean
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia.

Authors:  Michael B Rothberg; Marya D Zilberberg; Penelope S Pekow; Aruna Priya; Sarah Haessler; Raquel Belforti; Daniel Skiest; Tara Lagu; Thomas L Higgins; Peter K Lindenauer
Journal:  J Antimicrob Chemother       Date:  2015-01-03       Impact factor: 5.790

Review 4.  Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis.

Authors:  Anthony X Troitino; Jahan Porhomayon; Ali A El-Solh
Journal:  Lung       Date:  2013-04-10       Impact factor: 2.584

5.  Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients?

Authors:  Michael B Rothberg; Sarah Haessler; Tara Lagu; Peter K Lindenauer; Penelope S Pekow; Aruna Priya; Daniel Skiest; Marya D Zilberberg
Journal:  Infect Control Hosp Epidemiol       Date:  2014-10       Impact factor: 3.254

6.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

Review 7.  Predictors of mortality for nursing home-acquired pneumonia: a systematic review.

Authors:  Naveen Dhawan; Naushira Pandya; Michael Khalili; Manuel Bautista; Anurag Duggal; Jaya Bahl; Vineet Gupta
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

8.  Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia.

Authors:  Yun Seong Kang; Soo Ryeong Ryoo; Seung Joo Byun; Yun Jeong Jeong; Jin Young Oh; Young Soon Yoon
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

Review 9.  Microbiology of healthcare-associated infections and the definition accuracy to predict infection by potentially drug resistant pathogens: a systematic review.

Authors:  Teresa Cardoso; Mónica Almeida; Jordi Carratalà; Irene Aragão; Altamiro Costa-Pereira; António E Sarmento; Luís Azevedo
Journal:  BMC Infect Dis       Date:  2015-12-11       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.